MediWound Ltd.
MDWD- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001593984
In the last 90 days, MediWound Ltd. insiders filed 1 open-market purchase and 2 sales; 78 institutions reported holding it in 13F filings for Q2 2026, worth $85.5M in total; ARK Invest is the only superinvestor holding it.
13F holders, Q2 2023
Institutional positions in MediWound Ltd. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- −1 vs. Q1 2023
- Shares held
- 2.05M
- +70.0K (+3.5%) vs. Q1 2023
- Total value
- $21.8M
- −$4.59M (−17.4%) vs. Q1 2023
- New holders
- 1
- 6 more added
- Sold out
- 2
- 6 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MDWD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 78 | $85.5M |
| Q1 2026 | 76 | $97.3M |
| Q4 2025 | 78 | $114.7M |
| Q3 2025 | 76 | $104.1M |
| Q2 2025 | 68 | $86.0M |
| Q1 2025 | 64 | $66.6M |
| Q4 2024 | 64 | $79.0M |
| Q3 2024 | 63 | $76.0M |
| Q2 2024 | 45 | $40.8M |
| Q1 2024 | 31 | $31.2M |
| Q4 2023 | 22 | $25.6M |
| Q3 2023 | 18 | $20.9M |
| Q2 2023 | 20 | $21.8M |
| Q1 2023 | 21 | $26.4M |
| Q4 2022 | 19 | $11.0M |
| Q3 2022 | 28 | $12.2M |
| Q2 2022 | 20 | $5.63M |
| Q1 2022 | 28 | $5.50M |
| Q4 2021 | 29 | $8.63M |
| Q3 2021 | 26 | $11.8M |
| Q2 2021 | 24 | $13.6M |
| Q1 2021 | 27 | $26.2M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding MediWound Ltd.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 821,500 | $8.76M | 0.03% | 00.0% | Unchanged |
| DAFNA Capital Management LLC | 257,653 | $2.75M | 0.75% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 150,000 | $1.60M | 0.01% | 00.0% | Unchanged |
| Uniplan Investment Counsel, Inc. | 147,756 | $1.57M | 0.11% | +49,528+50.4% | Added |
| AWM Investment Company, Inc. | 142,857 | $1.50M | 0.20% | 00.0% | Unchanged |
| Wells Fargo & Company | 112,727 | $1.20M | 0.00% | +15,535+16.0% | Added |
| Sphera Funds Management Ltd. | 111,127 | $1.18M | 0.25% | 00.0% | Unchanged |
| Sargent Investment Group, LLC | 103,190 | $1.10M | 0.27% | +2,389+2.4% | Added |
| Essex Investment Management Co LLC | 55,907 | $596.0K | 0.08% | +1,295+2.4% | Added |
| Renaissance Technologies LLC | 55,644 | $593.0K | 0.00% | −1,200−2.1% | Reduced |
| Cowen Prime Advisors LLC | 33,409 | $350.8K | 0.12% | +10,639+46.7% | Added |
| Meitav Dash Investments Ltd | 31,502 | $320.2K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 15,238 | $162.4K | 0.00% | +8,392+122.6% | Added |
| Advisor Group Holdings, Inc. | 6,188 | $66.0K | 0.00% | −615−9.0% | Reduced |
| The PNC Financial Services Group, Inc. | 4,229 | $45.1K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 3,274 | $34.9K | 0.00% | −265−7.5% | Reduced |
| Tower Research Capital LLC (TRC) | 1,037 | $11.1K | 0.00% | −189−15.4% | Reduced |
| Steward Partners Investment Advisory, LLC | 143 | $1.52K | 0.00% | −72−33.5% | Reduced |
| UBS Group AG | 45 | $480 | 0.00% | −96−68.1% | Reduced |
| Royal Bank of Canada | 23 | $0 | 0.00% | +23 | New |
| Millennium Management LLC | 0 | $0 | 0.00% | −13,411−100.0% | Sold out |
| Dorsey Wright & Associates | 0 | $0 | 0.00% | −1,934−100.0% | Sold out |